Table 2 Recommendations where strength of agreement was agree (median ≥7) but variation in extent of agreement was high (MADM score >1.75)
Recommendation | Median | Mean absolute deviation from the median (MADM) | |
|---|---|---|---|
22 | All teams should have a designated person at each MDT meeting to help identify suitable patients for clinical trials | 7 | 1.88 |
23 | Patients should be given feedback on all treatment options, even those rejected by the MDT | 7 | 2.25 |
24 | Patients should be able to choose the mode of MDT meeting feedback (e.g. written, phone call, in clinic) | 7.5 | 2.19 |